AIXC - Qualigen Therapeutics, Inc.
1.125
0.075 6.667%
Share volume: 20,858
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.05
0.07
0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 07-02-2024 | 08-14-2024 | 11-14-2024 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||
| Operating expenses | 1.422 M | 1.741 M | 1.269 M | 1.413 M | 1.997 M | |
| Selling general and admin | 1.057 M | 986.484 K | 1.145 M | 1.395 M | 1.891 M | |
| Research and development | 364.385 K | 754.287 K | 123.429 K | 17.815 K | 105.576 K | |
| Total expenses | 1.422 M | 1.741 M | 1.269 M | 1.684 M | 1.430 M | |
| 22.44% | -27.13% | 32.73% | -15.09% | |||
| Operating income | -1.422 M | -1.741 M | -1.269 M | -1.684 M | -1.430 M | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -2.031 M | -1.478 M | -1.796 M | -1.685 M | -2.038 M | |
| -27.24% | 21.55% | -6.17% | 20.91% | |||
| Income tax | 1.786 K | -1.212 K | -2.198 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.033 M | -1.577 M | -1.794 M | -1.685 M | -2.038 M | |
| 22.44% | -13.80% | 6.06% | -20.91% |